Thromb Haemost 2017; 117(04): 820-821
DOI: 10.1160/TH17-02-0120
Author Correspondence
Schattauer GmbH

Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear interpolation: Reply

Joseph S. Biedermann
1   Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
2   Star-Medical Diagnostic Center, Rotterdam, The Netherlands
,
A. M. H. P. van den Besselaar
3   Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
,
Felix J. M. van der Meer
3   Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands
,
Henk J. Adriaansen
4   Department of Clinical Chemistry, Gelre Hospital, Apeldoorn, The Netherlands
,
Frank W. G. Leebeek
1   Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
,
Marieke J. H. A. Kruip
1   Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands
2   Star-Medical Diagnostic Center, Rotterdam, The Netherlands
› Author Affiliations
Further Information

Publication History

Received: 21 February 2017

Accepted: 23 February 2017

Publication Date:
28 November 2017 (online)

 

 
  • References

  • 1 Rosendaal FR, Cannegieter SC. Control of anticoagulation with VKAs: overestimation of median TTR when assessed by linear extrapolation: A comment. Thromb Haemost 2017; 117: 819
  • 2 Van den Besselaar AMHP, Biedermann JS, van der Meer FJM. et al. Control of anticoagulation with vitamin K antagonists: overestimation of median TTR when assessed by linear extrapolation. Thromb Haemost 2016; 116: 679-686
  • 3 Björck F, Renlund H, Lip G.Y.H. et al. Outcomes in a warfarin-treated population with atrial fibrillation. JAMA Cardiol 2016; 1: 172-180